Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HUSTED, Steen")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 50

  • Page / 2
Export

Selection :

  • and

Evidence-based prescribing and adherence to antiplatelet therapy―How much difference do they make to patients with atherothrombosis?HUSTED, Steen.International journal of cardiology. 2009, Vol 134, Num 2, pp 150-159, issn 0167-5273, 10 p.Article

Unmet needs in oral antiplatelet therapy with ADP receptor blocking agentsHUSTED, Steen.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 1-9, issn 0767-3981, 9 p.Article

Benefits and risks with antiplatelet therapy : how great a problem is bleeding?HUSTED, Steen.European heart journal supplements. 2008, Vol 10, Num I, issn 1520-765X, I19-I24Article

New developments in oral antiplatelet therapyHUSTED, Steen.European heart journal supplements. 2007, Vol 9D, issn 1520-765X, D20-D27Article

Dipyridamole and headache: a pilot study of initial dose titrationLINDGREN, Arne; HUSTED, Steen; STAAF, Gert et al.Journal of the neurological sciences. 2004, Vol 223, Num 2, pp 179-184, issn 0022-510X, 6 p.Article

Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery diseaseHUSTED, Steen; KHER, André.Annals of medicine (Helsinki). 2000, Vol 32, pp 53-59, issn 0785-3890, SUP1Conference Paper

New Oral Anticoagulants: A Review of the Literature with Particular Emphasis on Patients with Impaired Renal FunctionPOULSEN, Birgitte Klindt; GROVE, Erik Lerkevang; HUSTED, Steen Elkjaer et al.Drugs (Basel). 2012, Vol 72, Num 13, pp 1739-1753, issn 0012-6667, 15 p.Article

Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?ZEUTHEN, Elisabeth L; LASSEN, Jens F; HUSTED, Steen E et al.Thrombosis research. 2003, Vol 109, Num 5-6, pp 241-246, issn 0049-3848, 6 p.Article

Bedside coagulometry during intravenous heparin therapy after coronary angioplastySCHROEDER, Anne Pauline; KNUDSEN, Lars Lyhne; HUSTED, Steen E et al.Journal of thrombosis and thrombolysis. 2001, Vol 12, Num 2, pp 157-163, issn 0929-5305Article

Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or ClopidogrelHUSTED, Steen; STOREY, Robert F; HARRINGTON, RobertA et al.Clinical cardiology (Mahwah, NJ). 2010, Vol 33, Num 4, pp 206-212, issn 0160-9289, 7 p.Article

Trend in mortality after stroke with atrial fibrillation : CardiologyFROST, Lars; ANDERSEN, Ljubica Vukelic; VESTERGAARD, Peter et al.The American journal of medicine. 2007, Vol 120, Num 1, pp 47-53, issn 0002-9343, 7 p.Article

Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after Discharge from the Hospital with a diagnosis of atrial fibrillationFROST, Lars; ENGHOLM, Gerda; JOHNSEN, Søren et al.Archives of internal medicine (1960). 2001, Vol 161, Num 2, pp 272-276, issn 0003-9926Conference Paper

Venous Thromboembolism in Patients Having Knee Replacement and Receiving Thromboprophylaxis: A Danish Population-Based Follow-up StudyPEDERSEN, Alma B; MEHNERT, Frank; JOHNSEN, Soren P et al.Journal of bone and joint surgery. American volume (Print ed.). 2011, Vol 93A, Num 14, pp 1281-1287, issn 0021-9355, 7 p.Article

Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practicesHOLM, Tomas; DEUTCH, Susanna; LASSEN, Jens F et al.Thrombosis research. 2002, Vol 105, Num 2, pp 103-108, issn 0049-3848Article

Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) TrialMAHAFFEY, Kenneth W; HELD, Claes; KHURMI, Nardev S et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 15, pp 1493-1499, issn 0735-1097, 7 p.Article

Vitamin K antagonists in heart disease: Current status and perspectives (Section III): Position Paper of the ESC Working Group on Thrombosis ― Task Force on Anticoagulants in Heart DiseaseDE CATERINA, Raffaele; HUSTED, Steen; LIP, Gregory Y. H et al.Thrombosis and haemostasis. 2013, Vol 110, Num 6, pp 1087-1107, issn 0340-6245, 21 p.Article

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trialBECKER, Richard C; PIERRE BASSAND, Jean; LOPEZ-SENDON, Jose et al.European heart journal. 2011, Vol 32, Num 23, pp 2933-2944, issn 0195-668X, 12 p.Article

Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)STOREY, Robert F; BECKER, Richard C; CANNON, Christopher P et al.The American journal of cardiology. 2011, Vol 108, Num 11, pp 1542-1546, issn 0002-9149, 5 p.Article

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromesSTOREY, Robert F; HUSTED, Steen; CANNON, Christopher P et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 19, pp 1852-1856, issn 0735-1097, 5 p.Article

5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome : a follow-up study. CommentaryBACH, Richard G; LAGERQVIST, Bo; HUSTED, Steen et al.Lancet (British edition). 2006, Vol 368, Num 9540, issn 0140-6736, 966-969,998-1004 [11 p.]Article

Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non-ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) TrialWALLENTIN, Lars; LINDHOLM, Daniel; HELD, Claes et al.Circulation (New York, N.Y.). 2014, Vol 129, Num 3, pp 293-303, issn 0009-7322, 11 p.Article

Darapladib for Preventing Ischemic Events in Stable Coronary Heart DiseaseWHITE, Harvey D; HELD, Claes; ARMSTRONG, Paul W et al.The New England journal of medicine. 2014, Vol 370, Num 18, pp 1702-1711, issn 0028-4793, 10 p.Article

General mechanisms of coagulation and targets of anticoagulants (Section I): Position Paper of the ESC Working Group on Thrombosis ― Task Force on Anticoagulants in Heart DiseaseDE CATERINA, Raffaele; HUSTED, Steen; LIP, Gregory Y. H et al.Thrombosis and haemostasis. 2013, Vol 109, Num 4, pp 569-579, issn 0340-6245, 11 p.Article

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic AttackJAMES, Stefan K; STOREY, Robert F; PAIS, Prem et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 23, pp 2914-2921, issn 0009-7322, 8 p.Article

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From the PLATO (Platelet Inhibition and Patient Outcomes) TrialHELD, Claes; ASENBLAD, Nils; MAHAFFEY, Kenneth W et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 6, pp 672-684, issn 0735-1097, 13 p.Article

  • Page / 2